Cargando…

The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention

BACKGROUND AND OBJECTIVES: The outcome benefits of β-blockers in chronic coronary artery disease (CAD) have not been fully assessed. We evaluated the prognostic impact of β-blockers on patients with chronic CAD after percutaneous coronary intervention (PCI). METHODS: A total of 3,075 patients with c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jiesuck, Han, Jung-Kyu, Kang, Jeehoon, Chae, In-Ho, Lee, Sung Yun, Choi, Young Jin, Rhew, Jay Young, Rha, Seung-Woon, Shin, Eun-Seok, Woo, Seong-Ill, Lee, Han Cheol, Chun, Kook-Jin, Kim, DooIl, Jeong, Jin-Ok, Bae, Jang-Whan, Yang, Han-Mo, Park, Kyung Woo, Kang, Hyun-Jae, Koo, Bon-Kwon, Kim, Hyo-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257156/ https://www.ncbi.nlm.nih.gov/pubmed/35491482 http://dx.doi.org/10.4070/kcj.2021.0395

Ejemplares similares

Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry
por: Shin, Eun-Seok, et al.
Publicado: (2023)

Complete Revascularization of Multivessel Coronary Artery Disease Does Not Improve Clinical Outcome in ST-Segment Elevation Myocardial Infarction Patients with Reduced Left Ventricular Ejection Fraction
por: Kang, Jeehoon, et al.
Publicado: (2020)

The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography
por: Kang, Jeehoon, et al.
Publicado: (2018)

Impact of Intensive Glucose Control in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: 3-Year Clinical Outcomes
por: Park, Jiesuck, et al.
Publicado: (2020)

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2020)

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Kwon, Soonil, et al.
Publicado: (2021)

Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2022)

Effect of Beta Blockers and Renin–Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lee, Pil Hyung, et al.
Publicado: (2016)

Association Between Low Muscle Mass and Prognosis of Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Kim, Chi‐Hoon, et al.
Publicado: (2020)

Role of Coronary Artery Calcium Scoring in Detection of Coronary Artery Disease according to Framingham Risk Score in Populations with Low to Intermediate Risks
por: Kim, Won-Jang, et al.
Publicado: (2016)

Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study
por: Park, Jiesuck, et al.
Publicado: (2021)

Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study
por: Chung, Jaehoon, et al.
Publicado: (2017)

Cost-Effectiveness of Clopidogrel vs Aspirin Monotherapy After Percutaneous Coronary Intervention: Results From the HOST-EXAM Study
por: Hwang, Doyeon, et al.
Publicado: (2023)

Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study
por: Park, Jiesuck, et al.
Publicado: (2019)

Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management
por: Lee, Pil Hyung, et al.
Publicado: (2020)

Sarcopenia Index as a Predictor of Clinical Outcomes in Older Patients with Coronary Artery Disease
por: Lee, Hak Seung, et al.
Publicado: (2020)

Efficacy and Safety of Long-Term and Short-Term Dual Antiplatelet Therapy: A Meta-Analysis of Comparison between Asians and Non-Asians
por: Ki, You-Jeong, et al.
Publicado: (2020)

Angiographic complete revascularization versus incomplete revascularization in patients with diabetes mellitus
por: Hwang, Doyeon, et al.
Publicado: (2022)

Long-Term Clinical Benefits of a Platelet Glycoprotein IIb/IIIa Receptor Blocker, Abciximab (ReoPro(®)), in High-Risk Diabetic Patients undergoing Percutaneous Coronary Intervention
por: Sim, Doo Sun, et al.
Publicado: (2003)

Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI
por: Ki, You-Jeong, et al.
Publicado: (2021)

Clinical Characteristics of Coronary Drug-Eluting Stent Fracture: Insights from a Two-Center DES Registry
por: Park, Kyung Woo, et al.
Publicado: (2011)

Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function
por: Yun, Jun Pil, et al.
Publicado: (2023)

SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era
por: Kang, Jeehoon, et al.
Publicado: (2019)

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2022)

Harmonizing Optimal Strategy for Treatment of coronary artery diseases – comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial
por: Lee, Joo Myung, et al.
Publicado: (2015)

Erratum: Correction of Text in the Article “Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI”
por: Ki, You-Jeong, et al.
Publicado: (2022)

Coronary Computed Tomography Angiography for the Diagnosis of Vasospastic Angina: Comparison with Invasive Coronary Angiography and Ergonovine Provocation Test
por: Park, Jiesuck, et al.
Publicado: (2019)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Impact of Follow-Up Ischemia on Myocardial Perfusion Single-Photon Emission Computed Tomography in Patients with Coronary Artery Disease
por: Kang, Se Hun, et al.
Publicado: (2017)

The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 & 2016 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry
por: Shin, Dong-Ho, et al.
Publicado: (2019)

Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea
por: Kwon, Osung, et al.
Publicado: (2018)

Long-term use of renin-angiotensin-system inhibitors after acute myocardial infarction is not associated with survival benefits: Analysis of data from the Korean acute myocardial infarction registry-national institutes of health registry
por: Park, Chan Soon, et al.
Publicado: (2022)

Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
por: Kang, Se Hun, et al.
Publicado: (2017)

Clinical Impact and Cost-Effectiveness of Coronary Computed Tomography Angiography or Exercise Electrocardiogram in Individuals Without Known Cardiovascular Disease
por: Park, Gyung-Min, et al.
Publicado: (2015)

Sex-related impacts on clinical outcomes after percutaneous coronary intervention
por: Park, Hyun Woo, et al.
Publicado: (2020)

Assessment of coronary spasms with transluminal attenuation gradient in coronary computed tomography angiography
por: Park, Jae Yang, et al.
Publicado: (2022)

Intracranial Bleeding After Percutaneous Coronary Intervention: Time‐Dependent Incidence, Predictors, and Impact on Mortality
por: Lee, Pil Hyung, et al.
Publicado: (2021)

Relationship between Peripheral Leukocyte Count and the Severity of Stable Angina Determined by Coronary Angiography
por: Park, Seung Ha, et al.
Publicado: (2004)

Extremely Low Activity of Serum Alanine Aminotransferase Is Associated with Long-Term Overall-Cause Mortality in the Elderly Patients Undergoing Percutaneous Coronary Intervention after Acute Coronary Syndrome
por: Kim, Doo Young, et al.
Publicado: (2023)

An Elevated Value of C-Reactive Protein is the Only Predictive Factor of Restenosis after Percutaneous Coronary Intervention
por: Jeong, Woo Kon, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_lsdrb08nqrhoj7bm1jttmf3d59